Physician profile
Katrina Burgos
NPI 1023665619
$13,238.03
in general payments reported to CMS, 2019-2025
46 companies · $1,688 in 2025
The $1,688 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,459 · 2022: $2,706 · 2023: $2,945 · 2024: $3,440 · 2025: $1,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,061 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,060.98 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,308.41 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,762.48 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,728.06 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $951.48 | 2021-2025 | Jardiance, Tradjenta, Spiriva Respimat |
| Lilly USA, LLC | $838.24 | 2021-2025 | Mounjaro, Jardiance, Kisunla |
| Pfizer INC. | $663.44 | 2021-2025 | |
| Amgen INC. | $573.76 | 2021-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $424.75 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $412.08 | 2021-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Astellas Pharma US INC | $400.19 | 2021-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $336.33 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $317.76 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $317.43 | 2023-2025 | Freestyle Libre 3, Absorb Gt1 |
| Otsuka America Pharmaceutical, INC. | $232.64 | 2021-2025 | Rexulti, Nuedexta |
| Biohaven Pharmaceutical Holding Company LTD. | $224.33 | 2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Burgos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.